Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1). HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by transmission of infected T lymphocytes through blood transfusion. One to ten percent of infected carriers will develop a severe HTLV-1-associated disease: Adult-T-cell leukemia/lymphoma (ATLL), or a neurological disorder n...

The clinicopathologic features of a Korean patient with adult T-cell leukemia/lymphoma(ATLL) are presented. A 51-year-old man, who has lived in Korea since birth, had multiple cutaneous nodules and multiple lymphadenopathy for the previous two months. A histopathologic study of the lymph node and skin lesion revealed T-cell non-Hodgkin's lymphoma of pleomorphic type, medium and large cell type....

The drinking water network of Aigües del Ter-Llobregat (ATLL) has applied a methodology to obtain a reliable data. The methodology is based on a first phase to validate the data with six levels and a second phase that they analysis and reconstruct the non-validate data. INTRODUCTION Every day, the telecontrol system supervised the whole network status. This process needs accurate and reliable s...

Gallo and co-workers first described human T-cell leukemia virus (HTL V), a type C retrovirus isolated from an aggressive case of cutaneous T-cell lymphoma [27, 28]. Cases of adult T-cell leukemia/lymphoma (A1LL) , a unique mature T-cell malignancy, have also yielded numerous other isolates of H1LV [23, 7, 17, 35, 10, 29]. ATLL is seen at increased levels in southwestern Japan and the Caribbean...

We synthesized 46 sequential peptides 21 to 39 amino acids long over the structural protein of human T-cell leukemia virus type I (HTLV-I; the p19 and p24 gag protein and the gp46 and p20E env proteins) and tested their reactivities against antibodies in sera from HTLV-I healthy carriers and patients diagnosed as having human T-cell leukemia-lymphoma (ATLL) and myelopathy (HAM) by using an enzy...

The classification of non-Hodgkin lymphoma (NHL) has evolved steadily over the past several decades. In the 1950s, Rappaport et al. [1] recognized the importance of the growth pattern in NHL and used the pattern, in addition to the cell size and shape, as the basis of a clinically relevant classification. In the 1970s, recognition that NHL cells were derived from T or B cells led to the immunol...